CymitQuimica logo
Angiogenesis

Angiogenesis

Angiogenesis inhibitors are compounds that interfere with the formation of new blood vessels, a process critical in cancer growth and metastasis. By inhibiting angiogenesis, these compounds can restrict the blood supply to tumors, slowing or halting their growth. Angiogenesis inhibitors are essential in cancer research and therapeutic development, providing insights into the mechanisms of tumor progression and offering potential treatments for cancer and other angiogenesis-related diseases. At CymitQuimica, we offer a wide range of high-quality angiogenesis inhibitors to support your research in oncology and vascular biology.

Subcategories of "Angiogenesis"

Show 6 more subcategories

Found 2382 products of "Angiogenesis"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • Simotinib hydrochloride

    CAS:
    Simotinib hydrochloride: selective oral EGFR inhibitor, IC50 19.9 nM, potent anticancer agent.
    Formula:C25H27Cl2FN4O4
    Color and Shape:Solid
    Molecular weight:537.41

    Ref: TM-T39019

    5mg
    873.00€
  • CS-VIP 8


    CS-VIP 8 is a selective allosteric inhibitor of the WDR5 protein (Ki= 0.008 μM). It induces conformational changes in the MLL1 complex, causing the dissociation of MLL1 from the complex and inhibiting MLL1 histone methyltransferase activity, thereby regulating HOX gene expression. CS-VIP 8 shows potential for research in hematological diseases such as leukemia.
    Formula:C43H52F4N12O7
    Color and Shape:Solid
    Molecular weight:924.4018

    Ref: TM-T207515

    10mg
    To inquire
    50mg
    To inquire
  • DP-C-4


    DP-C-4 is a Cereblon-based dual PROTAC for simultaneous degradation of EGFR and PARP[1].
    Color and Shape:Liquid

    Ref: TM-T36251

    1mg
    208.00€
    5mg
    627.00€
    10mg
    1,009.00€
  • Secretin, canine

    CAS:
    Secretin: endocrine hormone, increases bicarbonate-rich pancreatic fluid, regulates canine gastric functions via Src kinase pathway.
    Formula:C131H222N44O41
    Purity:98%
    Color and Shape:Solid
    Molecular weight:3069.43

    Ref: TM-TP1610

    100mg
    To inquire
    500mg
    To inquire
  • Lck degrader-1


    Lckdegrader-1 (Compound 17) is a molecular glue degrader that targets lymphocyte-specific protein tyrosine kinase (LCK) with a DC50 of 23.1 nM. It holds potential for research in T-cell acute lymphoblastic leukemia (T-ALL).
    Color and Shape:Odour Solid

    Ref: TM-T211514

    10mg
    To inquire
    50mg
    To inquire
  • FAK-IN-24

    CAS:
    FAK-IN-24 (Compound 9f) is a potent FAK inhibitor with an IC50 of 0.815 nM. It induces DNA damage and apoptosis, and exhibits activity against glioblastoma. FAK-IN-24 effectively inhibits proliferation of glioblastoma cell lines U87-MG (IC50= 15 nM) and U251 (IC50= 20 nM), and suppresses tumor growth in U87-MG xenograft models.
    Formula:C39H45Cl2F3N8O3
    Color and Shape:Solid
    Molecular weight:801.728

    Ref: TM-T205467

    10mg
    To inquire
    50mg
    To inquire
  • VEGFR-2-IN-56


    VEGFR-2-IN-56 (compound 12e) exhibits the strongest inhibition activity against VEGFR-2, with an IC50 value of 45.9 nM.
    Color and Shape:Odour Solid

    Ref: TM-T200630

    10mg
    To inquire
    50mg
    To inquire
  • Wu-5

    CAS:
    Wu-5 is a potent USP10 inhibitor that inhibits FLT3 and AMPK pathways, promoting the breakdown of FLT3-ITD and inducing apoptosis.
    Formula:C15H13NO7S
    Purity:99.65%
    Color and Shape:Soild
    Molecular weight:351.33

    Ref: TM-T77763

    1mg
    79.00€
    5mg
    156.00€
    10mg
    235.00€
    25mg
    378.00€
    50mg
    540.00€
    100mg
    747.00€
    200mg
    1,026.00€
  • SNIPER(ABL)-024

    CAS:
    SNIPER(ABL)-024, a compound that conjugates GNF5 (ABL inhibitor) to an LCL161 derivative (IAP ligand) via a linker, effectively reduces BCR-ABL protein levels,
    Formula:C52H61F3N8O9S
    Purity:98%
    Color and Shape:Solid
    Molecular weight:1031.15

    Ref: TM-T18688

    100mg
    To inquire
    500mg
    To inquire
  • Lyn peptide inhibitor

    CAS:
    Inhibits Lyn kinase, blocks IL-5 receptor, prevents eosinophil differentiation and reduces asthma-related inflammation in mice.
    Formula:C115H184N30O24
    Purity:98%
    Color and Shape:Solid
    Molecular weight:2370.91

    Ref: TM-TP2008

    1mg
    334.00€
  • GSK143

    CAS:
    GSK143: Oral SYK inhibitor, pIC50=7.5, curbs pErk, anti-inflammatory, hinders immune cells in mice.
    Formula:C17H22N6O2
    Color and Shape:Solid
    Molecular weight:342.403

    Ref: TM-T38626

    5mg
    873.00€
  • MR44397


    MR44397 is a ligand for WD40 repeat (WDR) 5 and is applicable in cancer research.
    Formula:C23H26N4O2S
    Color and Shape:Solid
    Molecular weight:422.54

    Ref: TM-T203164

    10mg
    To inquire
    50mg
    To inquire
  • DBL-6-13


    DBL-6-13 is an inhibitor of WDR5, displaying moderate binding affinity with dissociation constants (Kd) of 6.8 μM and 9.1 μM as determined by microscale thermophoresis analysis and fluorescence polarization analysis, respectively.
    Formula:C25H38N4O3
    Color and Shape:Solid
    Molecular weight:442.59

    Ref: TM-T203576

    10mg
    To inquire
    50mg
    To inquire
  • K882


    K882 (Compound 4e) is an Src inhibitor with a KD of 0.315 μM. It induces apoptosis and inhibits XIAP and Survivin. Additionally, K882 blocks the activation of the PI3K/Akt/mTOR, Jak1/Stat3, and Ras/MAPK signaling pathways. K882 exhibits antitumor activity against non-small cell lung cancer.
    Formula:C18H16N2O2
    Color and Shape:Solid
    Molecular weight:292.33

    Ref: TM-T205438

    10mg
    To inquire
    50mg
    To inquire
  • EGFR/VEGFR2-IN-1


    EGFR/VEGFR2-IN-1 (Compound 10e) serves as an inhibitor for VEGFR-2 and EGFR, with respective IC50 values of 0.26 and 0.14 μM. It inhibits microtubule protein polymerization with an IC50 of 40.9 μM and induces cell apoptosis (Apoptosis). EGFR/VEGFR2-IN-1 is applicable in research related to anti-leukemia and anti-lymphoma treatments.
    Color and Shape:Odour Solid

    Ref: TM-T200716

    10mg
    To inquire
    50mg
    To inquire
  • ALK-IN-29


    ALK-IN-29 (compound 4c) exhibits inhibitory effects on tyrosine protein kinases such as ALK, CDK2/CyclinE1, and FAK, with the strongest inhibition observed against ALK kinase, displaying a 40.63% inhibition rate at a concentration of 10 μM. ALK-IN-29 is applicable in cancer research.
    Formula:C29H32FN3O
    Color and Shape:Solid
    Molecular weight:457.58

    Ref: TM-T201303

    10mg
    To inquire
    50mg
    To inquire
  • SIAIS100


    SIAIS100, a potent BCR-ABL PROTAC degrader, demonstrates a DC50 value of 2.7 nM, highlighting its efficacy.
    Formula:C44H50ClF2N9O5S
    Color and Shape:Solid
    Molecular weight:890.44

    Ref: TM-T75012

    5mg
    To inquire
    50mg
    To inquire
  • DSPE-PEG5000-GE11


    DSPE-PEG5000-GE11 is a PEG compound composed of DSPE and the EGFR-targeting peptide (GE11). GE11 is applicable for cancer cells with EGFR overexpression. DSPE-PEG5000-GE11 is utilized in drug delivery.
    Color and Shape:Odour Solid

    Ref: TM-TCL-01068

    10mg
    To inquire
    50mg
    To inquire
  • IMC-2C5


    IMC-2C5 is a humanized monoclonal antibody targeting PDGFRB/CD140b.
    Purity:>95%
    Color and Shape:Liquid
    Molecular weight:145.06 kDa

    Ref: TM-T9901A-227

    1mg
    436.00€
    5mg
    1,343.00€
    10mg
    2,080.00€
    25mg
    3,910.00€
  • FGFR1/VEGFR2-IN-3


    FGFR1/VEGFR2-IN-3 (Compound 8m) acts as a dual inhibitor of FGFR1 and VEGFR2. This compound exhibits both anti-cancer cell proliferation and anti-migration activities, and it also has the capability to induce cell apoptosis (apoptosis).
    Formula:C27H18N4O4
    Color and Shape:Solid
    Molecular weight:462.46

    Ref: TM-T200944

    10mg
    To inquire
    50mg
    To inquire